SCHEMBL26548744

SCHEMBL26548744

CCOc1ccnc(NC(C)C)c1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NOS1 P29475 1/20 0.44
NOS2 P35228 1/20 0.44
NPC1 O15118 1/20 0.40
PKM P14618 1/20 0.40
RAB9A P51151 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.40
MEN1 O00255 2/20 0.40
KMT2A Q03164 2/20 0.40
CYP1A2 P05177 1/20 0.40
MAPK14 Q16539 3/20 0.39
MAPK10 P53779 2/20 0.39
HRH4 Q9H3N8 1/20 0.39
NQO1 P15559 1/20 0.39
SYK P43405 1/20 0.39
FDPS P14324 1/20 0.38
CACNA2D1 P54289 1/20 0.38
HTR7 P34969 1/20 0.37
TP53 P04637 1/20 0.37
CYP3A4 P08684 1/20 0.37
HPGD P15428 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26548519 0.82 CCR1 (0.52) NOS1NOS2MAPK14MAPK10HRH4
SCHEMBL26550285 0.82 MAPK14 (0.41) MAPK14MAPK10HRH4FDPSHTR7
SCHEMBL26547682 0.81 CYP2C9 (0.43) MEN1KMT2ACYP1A2MAPK14MAPK10
SCHEMBL26550286 0.81 HTR7 (0.40) SMN1; SMN2MAPK14MAPK10HRH4FDPS
SCHEMBL26550280 0.81 FDPS (0.48) MAPK14MAPK10HRH4FDPSHTR7
SCHEMBL23763303 0.80 NOS1 (0.47) NOS1NOS2NPC1PKMRAB9A
SCHEMBL26550287 0.80 CHRNB2 (0.44) HTR7
SCHEMBL26548746 0.79 FDPS (0.48) MAPK14MAPK10HRH4FDPS
SCHEMBL25229618 0.79 NOS1 (0.46) NOS1NOS2NPC1PKMRAB9A
SCHEMBL26548755 0.79 KDM4E (0.44) SMN1; SMN2CYP1A2HTR7CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023196975-A1 COMPOUNDS THAT INTERACT WITH RAS SUPERFAMILY PROTEINS FOR TREATMENT OF CANCERS, INFLAMMATORY DISEASES, RASOPATHIES, AND FIBROTIC DISEASE SHY THERAPEUTICS, LLC (US) 2023-10-12 WO disclosed